Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients

NCT02755844 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Endometrial Cancer

Interventions

DRUG: Olaparib
DRUG: metformin
DRUG: metronomic cyclophosphamide

Sponsor

Hospices Civils de Lyon